Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Jiangsu HengRui Medicine Co., Ltd.
Scientific Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer